O Manuel

Summary

Affiliation: Provincial Laboratory for Public Health (Microbiology
Country: Canada

Publications

  1. ncbi Comparison of quantiferon-TB gold with tuberculin skin test for detecting latent tuberculosis infection prior to liver transplantation
    O Manuel
    Transplant Infectious Diseases, and Microbiology, University of Alberta, Edmonton, Alberta, Canada
    Am J Transplant 7:2797-801. 2007
  2. ncbi Incidence and clinical characteristics of herpes zoster after lung transplantation
    Oriol Manuel
    Department of Transplant Infectious Diseases, University of Alberta, Edmonton, Alberta, Canada
    J Heart Lung Transplant 27:11-6. 2008
  3. ncbi QuantiFERON-TB Gold assay for the diagnosis of latent tuberculosis infection
    Oriol Manuel
    Provincial Laboratory for Public Health Microbiology, University of Alberta Hospital, WMC 2B4 57, 8440 122 Street, Edmonton, AB, Canada
    Expert Rev Mol Diagn 8:247-56. 2008
  4. ncbi Cell-mediated immunity to predict cytomegalovirus disease in high-risk solid organ transplant recipients
    D Kumar
    Transplant Infectious Diseases, University of Alberta, Edmonton, Alberta, Canada
    Am J Transplant 9:1214-22. 2009
  5. ncbi Immunogenicity and safety of an intradermal boosting strategy for vaccination against influenza in lung transplant recipients
    O Manuel
    Transplant Infectious Diseases, University of Alberta, Edmonton, Alberta, Canada
    Am J Transplant 7:2567-72. 2007
  6. ncbi Oral valganciclovir for cytomegalovirus colitis after liver transplantation
    Oriol Manuel
    Transplantation 83:239-40. 2007
  7. ncbi Late-onset cytomegalovirus disease in patients with solid organ transplant
    Pascal R Meylan
    Microbiology Institute and Infectious Diseases Service, University Hospital, Lausanne, Switzerland
    Curr Opin Infect Dis 20:412-8. 2007
  8. ncbi Efficacy and safety of universal valganciclovir prophylaxis combined with a tacrolimus/mycophenolate-based regimen in kidney transplantation
    Oriol Manuel
    Transplantation Centre, Centre Hospitalier Universitaire Vaudois, University Hospital of Lausanne, CH 1011 Lausanne, Switzerland
    Swiss Med Wkly 137:669-76. 2007
  9. ncbi Cost-effectiveness of a new combined immunosuppressive and anti-infectious regimen in kidney transplantation
    Jean Blaise Wasserfallen
    Institute of Health Economics and Management, University of Lausanne, Lausanne, Switzerland
    Int J Technol Assess Health Care 24:312-7. 2008

Collaborators

Detail Information

Publications9

  1. ncbi Comparison of quantiferon-TB gold with tuberculin skin test for detecting latent tuberculosis infection prior to liver transplantation
    O Manuel
    Transplant Infectious Diseases, and Microbiology, University of Alberta, Edmonton, Alberta, Canada
    Am J Transplant 7:2797-801. 2007
    ..In patients awaiting liver transplantation, both the TST and QFT-G were comparable for the diagnosis of LTBI with reasonable concordance between tests. Indeterminate QFT-G result was more likely in those with more advanced liver disease...
  2. ncbi Incidence and clinical characteristics of herpes zoster after lung transplantation
    Oriol Manuel
    Department of Transplant Infectious Diseases, University of Alberta, Edmonton, Alberta, Canada
    J Heart Lung Transplant 27:11-6. 2008
    ..Epidemiologic data in lung transplant recipients are lacking. We determined the incidence and clinical characteristics of herpes zoster, and the risk factors for developing herpes zoster, after lung transplantation...
  3. ncbi QuantiFERON-TB Gold assay for the diagnosis of latent tuberculosis infection
    Oriol Manuel
    Provincial Laboratory for Public Health Microbiology, University of Alberta Hospital, WMC 2B4 57, 8440 122 Street, Edmonton, AB, Canada
    Expert Rev Mol Diagn 8:247-56. 2008
    ..In contrast to TST, there are no prospective studies regarding the association of the QFT-G result and the risk for development of TB. Given its advantages, the QFT-G may become the standard test for the diagnosis of LTBI...
  4. ncbi Cell-mediated immunity to predict cytomegalovirus disease in high-risk solid organ transplant recipients
    D Kumar
    Transplant Infectious Diseases, University of Alberta, Edmonton, Alberta, Canada
    Am J Transplant 9:1214-22. 2009
    ..0%) patients with a detectable interferon-gamma response (cutoff 0.1 IU/mL) versus 10/25 (40.0%) patients with a negative CMI, p = 0.12. Monitoring of CMI may be useful for predicting late-onset CMV disease...
  5. ncbi Immunogenicity and safety of an intradermal boosting strategy for vaccination against influenza in lung transplant recipients
    O Manuel
    Transplant Infectious Diseases, University of Alberta, Edmonton, Alberta, Canada
    Am J Transplant 7:2567-72. 2007
    ..024). After a single standard dose of influenza vaccine, a booster dose given by intradermal injection did not significantly improve vaccine immunogenicity in lung transplant recipients...
  6. ncbi Oral valganciclovir for cytomegalovirus colitis after liver transplantation
    Oriol Manuel
    Transplantation 83:239-40. 2007
  7. ncbi Late-onset cytomegalovirus disease in patients with solid organ transplant
    Pascal R Meylan
    Microbiology Institute and Infectious Diseases Service, University Hospital, Lausanne, Switzerland
    Curr Opin Infect Dis 20:412-8. 2007
    ..To review existing data regarding late cytomegalovirus disease occurring after antiviral prophylaxis...
  8. ncbi Efficacy and safety of universal valganciclovir prophylaxis combined with a tacrolimus/mycophenolate-based regimen in kidney transplantation
    Oriol Manuel
    Transplantation Centre, Centre Hospitalier Universitaire Vaudois, University Hospital of Lausanne, CH 1011 Lausanne, Switzerland
    Swiss Med Wkly 137:669-76. 2007
    ..We assessed the efficacy and safety of the introduction of universal valganciclovir prophylaxis in combination with a tacrolimus/mycophenolate-based regimen in kidney transplantation at our centre...
  9. ncbi Cost-effectiveness of a new combined immunosuppressive and anti-infectious regimen in kidney transplantation
    Jean Blaise Wasserfallen
    Institute of Health Economics and Management, University of Lausanne, Lausanne, Switzerland
    Int J Technol Assess Health Care 24:312-7. 2008
    ..The aims of this study were to assess the 1-year cost-effectiveness of a new combined immunosuppressive and anti-infectious regimen in kidney transplantation to prevent both rejection and infectious complications...